Lv1
30 积分 2022-09-04 加入
Nanobody-based bispecific antibody engagers targeting CTLA-4 or PD-L1 for cancer immunotherapy
23小时前
待确认
Valine-Alanine-Based Peptidomimetic Linker for Antibody-Drug Conjugates
2天前
已完结
Precisely deliver toll-like receptor agonists using a dual-responsive nanovaccine for effective cancer immunotherapy
9天前
已完结
Intelligent delivery of autophagy-targeting chimeric peptides by engineered exosomes for the degradation of α-synuclein
9天前
已完结
The Efficiency of Human Cytomegalovirus pp65495–503 CD8+ T Cell Epitope Generation Is Determined by the Balanced Activities of Cytosolic and Endoplasmic Reticulum-Resident Peptidases
9天前
已完结
An Engineered Nanovesicles-Based Lysosome-Targeting Protein Degradation Platform (NV-TACs) for Cancer Immunotherapy
24天前
已完结
Anchor peptide captures, targets, and loads exosomes of diverse origins for diagnostics and therapy
29天前
已完结
Anchor peptide captures, targets, and loads exosomes of diverse origins for diagnostics and therapy
29天前
已完结
Anchor peptide captures, targets, and loads exosomes of diverse origins for diagnostics and therapy
1个月前
已完结
Anchor peptide captures, targets, and loads exosomes of diverse origins for diagnostics and therapy
1个月前
已完结
皖公网安备34019202002308
